VEL-0230

CAT: 0931-MF-0144327-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0144327-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
221144-20-3
Target
Others|||Cysteine Protease
Related Pathways
Proteases/Proteasome|||Others
Bioactivity
VEL-0230, also known as NC-2300, is a potent cathespin K inhibitor. VEL-0230 has dual-acting properties that both stimulates bone formation and inhibits loss. VEL-0230 is being studied preclinically for the treatment of diseases involving bone mineral disorders such as bone loss related to multiple myeloma, osteoporosis, bone metastases, and rheumatoid arthritis. Velcura Therapeutics is currently being developed by Velcura Therapeutics. Given VEL- 0230's promotion of bone formation, inhibition of bone loss and reduction of calcium levels, Velcura has chosen Myeloma as its lead indication, as the bone fragility, bone pain, high calcium levels and eventual kidney involvement present serious medical and quality of life issues to affected patients.
Smiles
[Na+].CC(C)COC[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C([O-])=O
Molecular Formula
C14H24NNaO5
Molecular Weight
309.33
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0101392-01SIM-0235
MF-0146580-01EAPB 02303
MF-0142406-01HRX-0233
MF-0155185RDR 02308
MF-0031251-01TPA-023B
MF-0033964-01Ro-24-0238
MF-0143086-01NF 023
MF-0100681-01JCAR-023
MF-0147428-01DA-023
MF-0095188-01KM-023

Alternative Products

CatalogName
MBS5812338VEL-0230
1213888F42038-0230, Desiccator Plate, Ø 230 mm
MBS1428650-01Recombinant Leishmania major Anamorsin homolog (LmjF07.0230, LmjF_07_0230)

Popular Products